https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Incidence of toxicity was high (51%).Conclusion OS improved in this high-risk group over the years, especially after introduction of new treatment modalities. However, early death rate remains high, illustrating the need for more effective treatment.BACKGROUND Accurate awareness of the prognosis is an important factor in the treatment decision of patients with advanced cancer; however, prognostic disclosure is still subject to debate because it can reduce patient's satisfaction and increase depression. AIM The purpose of th
Like
Comment
Share
